Breaking News

Daiichi Sankyo Makes Executive Appointments

October 4, 2013

Gormley takes on president, chairman role, Barrett to head Commercial Division

Glenn Gormley, M.D., Ph.D., has been named corporate president and chairman of Daiichi Sankyo, Inc. Dr. Gormley will also continue in his roles as president, Daiichi Sankyo Pharma Development, global head of R&D, and senior executive officer of Daiichi Sankyo, Co. Ltd. 
 
Also, Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo, Inc. in the U.S. The company’s former president and chief executive officer, and head of its Commercial Division, John Gargiulo, left the company effective October 3, 2013.
 
Mr. Barrett will serve as acting president of Daiichi Sankyo Administrative & Commercial Operations, responsible for leading Daiichi’s U.S. Commercial Division including marketing, sales and supply chain operations. Mr. Barrett most recently served as vice president, Marketing and Managed Markets, at Daiichi Sankyo, Inc. and has been with the company since the late 1990's.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016